NFKB1 and head and neck squamous cell carcinoma: Treatment of HNSCC cells with guggulsterone abrogated ST- and nicotine-induced nuclear activation of NF-κB and pSTAT3 proteins, as well as the downstream targets COX-2 and vascular endothelial growth factor [137].